Cigna Group
CI Healthcare Healthcare Plans
Cigna Group’s revenue for fiscal 2025 (year ended December 2025) was $274.9 billion, up 11.2% from fiscal 2024. In the quarter to June 2026, revenue grew 6.68%, EPS grew 10.2%, free cash flow grew 66.9% and total debt rose 3.61%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten; insiders bought in the last twelve months.
Follow CI
Cigna Group (CI) EPS (diluted)
Cigna Group's EPS (diluted) for fiscal 2025 was $22.18, up 83.0% from $12.12 in fiscal 2024. Over the twelve months to 30 June 2026 it was $24.17. Over the past ten years it has ranged from $7.19 (fiscal 2016) to $22.96 (fiscal 2020); the current reading is higher than 91% of that period. Cigna Group ranks 1st of 12 Healthcare Plans companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | $22.18 | 83.00% |
| FY2024 | $12.12 | (30.30%) |
| FY2023 | $17.39 | (18.36%) |
| FY2022 | $21.30 | 35.41% |
| FY2021 | $15.73 | (31.49%) |
| FY2020 | $22.96 | 70.83% |
| FY2019 | $13.44 | 27.51% |
| FY2018 | $10.54 | 20.18% |
| FY2017 | $8.77 | 21.97% |
| FY2016 | $7.19 | (10.57%) |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Jun 2026 | $6.29 | 0.48% |
| Mar 2026 | $6.26 | 34.91% |
| Dec 2025 | $4.64 | (33.52%) |
| Sep 2025 | $6.98 | 22.24% |
| 42 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| CI Cigna Group | $24.17 |
| ELV Elevance Health, Inc. compare | $22.50 |
| UNH UnitedHealth Group Incorporated compare | $15.54 |
| HUM Humana Inc. compare | $10.57 |
| CVS CVS Health Corporation compare | $3.78 |
| OSCR Oscar Health, Inc. compare | $1.40 |
| CLOV Clover Health Investments, Corp. compare | −$0.05 |
| MOH Molina Healthcare, Inc compare | −$0.18 |
| CNC Centene Corporation compare | −$10.44 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on CI
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement